Status:

COMPLETED

Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis

Lead Sponsor:

University of Cologne

Conditions:

Invasive Aspergillosis

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This study investigates the safety and tolerability as well as the efficacy and pharmacokinetics of caspofungin in four escalating dosages in adult patients with hematologic malignancies and proven or...

Detailed Description

Due to its efficacy and a broad antifungal spectrum against relevant fungal pathogens, lack of cross-resistance to azoles and amphotericin B, documented efficacy against human Aspergillus infections, ...

Eligibility Criteria

Inclusion

  • Immunocompromised due to hematologic malignancies, bone marrow failure syndromes, hematopoietic stem cell transplantation, solid organ transplantation, other conditions resulting in severe neutropenia, HIV infection, prolonged corticosteroid therapy, treatment with other immunosuppressive medications, or other immunocompromising conditions that place patients at risk for invasive fungal infections.
  • Evidence of proven or probable invasive aspergillosis, by modified EORTC criteria

Exclusion

  • Concomitant other systemic antifungal agents are not permitted on study.
  • Chronic invasive fungal infection, defined as signs/symptoms of invasive fungal infection present for \> 4 weeks preceding entry into study
  • Prior systemic therapy of ≥ 4 days with any polyene anti-fungal agent within 14 days of study enrollment
  • Prior systemic therapy of ≥ 4 days with non-polyenes for the current, documented IFI.

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2009

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT00404092

Start Date

October 1 2006

End Date

October 1 2009

Last Update

July 31 2013

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

University Hospital Gasthuisberg

Leuven, Belgium, 3000

2

Charité - Campus Benjamin Franklin

Berlin, Germany, 12200

3

Klinikum der Universität zu Köln

Cologne, Germany, 50924

4

Universitätsklinikum Münster

Münster, Germany, 48149